Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Diabetes: later-stage trial registry
86 of 342 indexed Diabetes trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #19 of 28,707 conditions by registered trial count.
342 US clinical trials · 86 currently recruiting · #19 of 28,707 conditions by registered trial count
Diabetes: 342 US clinical trials tracked, 86 recruiting.
Diabetes is the subject of 342 registered US clinical trials on ClinicalTrials.gov, 86 of them currently open to new participants. 55 are in Phase 3-4 (later-stage) and 36 in Phase 1-2 (earlier-stage). The most active sponsor is Novo Nordisk A/S, running 41 of these trials.
Enrollment posture brief
Registry condition diabetes
OPEN 86 | RECR 25% | LATE 55 | EARLY 36 | RANK #19 | SPON 41
Volume-matched condition peers
Nearest open-share peer: Low Back Pain (25% recruiting · 123 trials)
Diabetes lists 86 open slots (25% of 342 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Diabetes on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Diabetes is recruiting below its size-band peers.
86 of 342 indexed trials (25.1%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Diabetes trials is spread across many organizations.
Novo Nordisk A/S accounts for 41 of 342 trials (12%). 161 distinct sponsors appear on at least one study for this condition label.
-
Typical Diabetes enrolment sits around 150 participants.
Median target enrolment is 150 among the 339 trials that report a genuine target (sentinel values excluded). 144 of those (42.5%) plan for fewer than 100 participants.
-
Diabetes research is mostly interventional.
263 interventional and 79 observational studies make up this index (76.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
342 total, page 5 of 7
Diabetes Prevention Translation: the Healthy Lifestyle Project
University of Pittsburgh
NCT01050205
Glucose Risk Assessment in Employer Populations
DexCom
NCT04529824
Blood Glucose Monitoring System Clinical Study
Intuity Medical
NCT01327209
Real-world Aliskiren Use in Diabetic Patients
Novartis
NCT01393860
Using Patient Feedback to Improve Communication Regarding Glycemic Control to Patients With Diabetes
University of Pennsylvania
NCT01886170
Diabetes Remote Intervention to improVe Use of Evidence-based Medications
Brigham and Women's Hospital
NCT06046560
Trial to Examine Text-message Based mHealth in Emergency Department Patients With Diabetes
University of Southern California
NCT01403831
Quality IQ Patient Simulation Physician Practice Measurement and Engagement
Qure Healthcare
NCT03800901
Hyperglycemic Profiles in Obstructive Sleep Apnea: Effects of PAP Therapy
Johns Hopkins University
NCT02454153
Accuracy of Hemoglobin A1C to Predict Glycemia in HIV
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00433628
Strong People Strength Training Study
Cornell University
NCT04203563
TExT-MED + FANS Full Trial
University of Southern California
NCT03178773
Glucose Control Using 1,5-AG Testing
Qure Healthcare
NCT03765164
A 12-week Titrate Study TO Evaluate Safety, Tolerability AND Pharmacodynamics OF PF-06882961 IN Adults With Type 2 Diabetes Mellitus AND IN Non-diabetic Adults With Obesity
Pfizer
NCT04617275
Addressing The Role of Nutrition Education & Health Literacy in Diabetes Care
Vanderbilt University
NCT00715585
Diabetes in the Elderly: Prospective Study
Guillermo Umpierrez
NCT01131052
Lucica ® Glycated Albumin-L Clinical Program - Pivotal Study
Asahi Kasei Pharma Corporation
NCT02489773
Comparison Evaluation of Blood Glucose Meter Systems
Ascensia Diabetes Care
NCT01548885
Identifying Risk for Diabetes and Heart Disease in Women
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT01809288
Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: a Randomized Clinical Trial
Thomas Jefferson University
NCT04259047
Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Diabetes Mellitus (BEGIN™)
Novo Nordisk A/S
NCT01135992
Implementing Diabetes Group Visits in Community Health Centers
University of Chicago
NCT02347514
Take Charge of Your Diabetes
University of Pennsylvania
NCT01977495
Expanding Comparative Effectiveness Research (CER) Capability Through Complex Patient Relationship Management
Denver Health and Hospital Authority
NCT01391585
Canola Oil Multi-Centre Intervention Trial II
University of Manitoba
NCT02029833
Performance of a New Glucose Meter System in Children and Young Adults
Ascensia Diabetes Care
NCT00985257
Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients
Providence VA Medical Center
NCT00357955
User Study of an Investigational Blood Glucose Monitoring System
Ascensia Diabetes Care
NCT01447121
Technology-assisted Case Management in Adults With Type 2 Diabetes
State University of New York at Buffalo
NCT01373489
Evaluation of the A1CNow+ Test Kit
Ascensia Diabetes Care
NCT00798486
Using Health Information Technology (HIT) to Improve Ambulatory Chronic Disease Care: Smart Device Substudy
University of Missouri-Columbia
NCT00802152
Dietary Approaches to Stop Hypertension for Diabetes
Johns Hopkins University
NCT04286555
Nourishing the Community Through Culinary Medicine
The University of Texas Health Science Center, Houston
NCT05624775
Remote Management of Diabetic Patients Via Data Transmission by Accu-Chek 360 Software
Columbus Research Foundation
NCT00956800
Cystic Fibrosis - Insulin Deficiency, Early Action
Sydney Children's Hospitals Network
NCT01100892
A Complex Contraception Registry
University of California, San Diego
NCT02219269
Lifestyle Changes Through Exercise and Nutrition
Pennington Biomedical Research Center
NCT02863887
Urine pH as a Predictor of Diabetes
Northwell Health
NCT01017848
Intervention to Promote Weight Loss in Latinas At-risk for Diabetes
Temple University
NCT02088034
QBSAfe: A Novel Approach to Diabetes Management Focused on Quality of Life, Burden of Treatment, Social Integration and Avoidance of Future Events
Yale University
NCT04514523
Taste Perception and Chronic Disease Risk
Tufts University
NCT01023906
Nourishing the Community Through Culinary Medicine - Acres Homes
The University of Texas Health Science Center, Houston
NCT06096506
GLP1R Polymorphisms and Response to GLP1
Mayo Clinic
NCT00588380
Pilot Study on the Effects of a Plant-Strong Diet on Cardiovascular Risk Factors
Phoenix VA Health Care System
NCT03330548
Community Paramedicine Program to Improve Diabetes Care Quality, Equity, and Outcomes
Mayo Clinic
NCT04385758
Novofine Autocover Safety Needle Versus BD Safety Glide
Novo Nordisk A/S
NCT00121355
Sitagliptin Therapy to Improve Outcomes After Islet Autotransplant
University of Minnesota
NCT01186562
Evaluation of Modified Adhesives With Dexcom G6 Sensor
DexCom
NCT04840446
Assessment of Glycemic Control in Patients With Type 2 Diabetes Mellitus and Late Stage Chronic Kidney Disease
Northwell Health
NCT03383627
Improving Compliance With Metformin
US Department of Veterans Affairs
NCT00018616
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 23 |
| Phase 2 | 13 |
| Phase 3 | 37 |
| Phase 4 | 18 |
Top Sponsors
Named interventions
Most-linked intervention names on Diabetes records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Diabetes trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Diabetes page
342 registered trials, 86 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 86 Diabetes trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Novo Nordisk A/S sponsors the most Diabetes trials on record, review their full trial history before evaluating a specific study. See Novo Nordisk A/S's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diabetes condition card totals 342 registered trials; most-linked intervention insulin degludec; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.